Literature DB >> 19006473

Management of painful diabetic neuropathy.

Mitra Tavakoli1, Rayaz A Malik.   

Abstract

The commonest cause of peripheral neuropathy is diabetes and pain occurs in approximately 30% of diabetic patients with neuropathy. It is extremely distressing for the patient and poses significant difficulties in management, as no treatment to date provides total relief and the side effects of therapy limit dose titration. Understanding the pathogenesis of diabetic neuropathy may lead to the development of new treatments for preventing nerve damage. Furthermore, a better understanding of the mechanisms that modulate pain may lead to more effective relief of painful symptoms. This review provides an update on the assessment and treatment of painful diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19006473     DOI: 10.1517/14656560802498149

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  13 in total

1.  Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy.

Authors:  M M Jack; J M Ryals; D E Wright
Journal:  Diabetologia       Date:  2011-06-03       Impact factor: 10.122

Review 2.  Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease.

Authors:  Grace E Stutzmann; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

3.  The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy.

Authors:  Eric Davidson; Lawrence Coppey; Bao Lu; Victor Arballo; Nigel A Calcutt; Craig Gerard; Mark Yorek
Journal:  Exp Diabetes Res       Date:  2010-02-03

Review 4.  Neuropathic pain in diabetes--evidence for a central mechanism.

Authors:  Tanya Z Fischer; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

Review 5.  Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?

Authors:  Kevin L Farmer; Chengyuan Li; Rick T Dobrowsky
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

6.  Nanoparticle-encapsulated emodin decreases diabetic neuropathic pain probably via a mechanism involving P2X3 receptor in the dorsal root ganglia.

Authors:  Lin Li; Xuan Sheng; Shanhong Zhao; Lifang Zou; Xinyao Han; Yingxin Gong; Huilong Yuan; Liran Shi; Lili Guo; Tianyu Jia; Shuangmei Liu; Bing Wu; Zhihua Yi; Hui Liu; Yun Gao; Guilin Li; Guodong Li; Chunping Zhang; Hong Xu; Shangdong Liang
Journal:  Purinergic Signal       Date:  2017-08-24       Impact factor: 3.765

7.  LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia.

Authors:  Shouyu Wang; Hong Xu; Lifang Zou; Jinyang Xie; Hong Wu; Bing Wu; Zhihua Yi; Qiulan Lv; Xi Zhang; Mofeng Ying; Shuangmei Liu; Guilin Li; Yun Gao; Changshui Xu; Chunping Zhang; Yun Xue; Shangdong Liang
Journal:  Purinergic Signal       Date:  2015-12-19       Impact factor: 3.765

8.  lncRNA NONRATT021972 siRNA Decreases Diabetic Neuropathic Pain Mediated by the P2X3 Receptor in Dorsal Root Ganglia.

Authors:  Haiying Peng; Lifang Zou; Jinyan Xie; Hong Wu; Bing Wu; Gaochun Zhu; Qiulan Lv; Xi Zhang; Shuangmei Liu; Guilin Li; Hong Xu; Yun Gao; Changshui Xu; Chunping Zhang; Shouyu Wang; Yun Xue; Shangdong Liang
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

9.  Minocycline attenuates the development of diabetic neuropathy by modulating DREAM and BDNF protein expression in rat spinal cord.

Authors:  Che Aishah Nazariah Ismail; Rapeah Suppian; Che Badariah Abd Aziz; Idris Long
Journal:  J Diabetes Metab Disord       Date:  2019-05-18

10.  LncRNA NONRATT021972 Was Associated with Neuropathic Pain Scoring in Patients with Type 2 Diabetes.

Authors:  Wei Yu; Guo-Qing Zhao; Rang-Juan Cao; Zhi-Hua Zhu; Kai Li
Journal:  Behav Neurol       Date:  2017-08-08       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.